These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity. Martella G; De Persis C; Bonsi P; Natoli S; Cuomo D; Bernardi G; Calabresi P; Pisani A Epilepsia; 2005 May; 46(5):624-35. PubMed ID: 15857426 [TBL] [Abstract][Full Text] [Related]
10. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Calabresi P; Marti M; Picconi B; Saulle E; Costa C; Centonze D; Pisani F; Bernardi G Exp Neurol; 2003 Aug; 182(2):461-9. PubMed ID: 12895457 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Martella G; Costa C; Pisani A; Cupini LM; Bernardi G; Calabresi P Cephalalgia; 2008 Dec; 28(12):1315-26. PubMed ID: 18771493 [TBL] [Abstract][Full Text] [Related]
12. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Pisani A; Bonsi P; Martella G; De Persis C; Costa C; Pisani F; Bernardi G; Calabresi P Epilepsia; 2004 Jul; 45(7):719-28. PubMed ID: 15230693 [TBL] [Abstract][Full Text] [Related]
13. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Calabresi P; De Murtas M; Stefani A; Pisani A; Sancesario G; Mercuri NB; Bernardi G Epilepsia; 1995 Oct; 36(10):990-6. PubMed ID: 7555963 [TBL] [Abstract][Full Text] [Related]
14. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Stefani A; Pisani A; De Murtas M; Mercuri NB; Marciani MG; Calabresi P Epilepsia; 1995 Oct; 36(10):997-1002. PubMed ID: 7555964 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. Taverna S; Sancini G; Mantegazza M; Franceschetti S; Avanzini G J Pharmacol Exp Ther; 1999 Mar; 288(3):960-8. PubMed ID: 10027832 [TBL] [Abstract][Full Text] [Related]
16. Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors. Booker SA; Pires N; Cobb S; Soares-da-Silva P; Vida I Neuropharmacology; 2015 Jun; 93():103-15. PubMed ID: 25656478 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Margineanu DG; Klitgaard H Pharmacol Res; 2000 Oct; 42(4):281-5. PubMed ID: 10987984 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation. Wakita M; Kotani N; Kogure K; Akaike N J Pharmacol Exp Ther; 2014 Feb; 348(2):246-59. PubMed ID: 24259680 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of sodium current by carbamazepine in dorsal root ganglion neurons in vitro. Singh JN; Jain G; Ramarao P; Sharma SS Indian J Physiol Pharmacol; 2009; 53(2):147-54. PubMed ID: 20112818 [TBL] [Abstract][Full Text] [Related]
20. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients. Tumay Y; Altun Y; Ekmekci K; Ozkul Y Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]